Endoglin (CD 105) as a potential prognostic factor in neuroblastoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|5|770-775

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.5, 2015-05, pp. : 770-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I study of TRC105 anti‐endoglin (CD105) antibody in metastatic castration‐resistant prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 546-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of Ets‐1 oncoprotein and human endoglin (CD105) on the recurrence of non‐melanoma skin cancers

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 9, 2015-09 ,pp. : 989-995

John Wiley & Sons Inc

Access to resources Recommend Favorite

The potential of CD44 as a diagnostic and prognostic tool in oral cancer

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 6, 2015-07 ,pp. : 393-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 952-957

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: Analysis of CD G870A polymorphism, FISH and immunohistochemistry

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 3, 2015-03 ,pp. : 316-323

John Wiley & Sons Inc

Access to resources Recommend Favorite